Replies to post #137602 on Biotech Values

[hptaxis]

Very Impressive.

[biomaven0]

I must say I am surprised by the margin (but happy). I suspect all the discussion by the FDA of the REMS program was a significant signal to the panel.

Peter

[oc631]

20 yes, 2 no for QNEXA

Does anyone feel if one of the two drugs that make-up Qnexa wasn't generic the advisory panel would have voted differently?